Ku GY - Search Results

1

Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer.

Yu KH, Park J, Mittal A, Abou-Alfa GK, El Dika I, Epstein AS, Ilson DH, Kelsen DP, Ku GY, Li J, Park W, Varghese AM, Chou JF, Capanu M, Cooper B, Bartlett A, McCarthy D, Sangar V, McCarthy B, O'Reilly EM. Yu KH, et al. Among authors: ku gy. Cancer. 2022 Aug 1;128(15):2958-2966. doi: 10.1002/cncr.34269. Epub 2022 Jun 1. Cancer. 2022. PMID: 35647938 Free PMC article. Clinical Trial.

2

A dramatic response to long-acting octreotide in metastatic hepatocellular carcinoma.

Deming DA, Stella AL, Holen KD, Ku G, O'Reilly EM. Deming DA, et al. Clin Adv Hematol Oncol. 2005 Jun;3(6):468-72; discussion 472-4. Clin Adv Hematol Oncol. 2005. PMID: 16167024 No abstract available.

3

Successful treatment of leptomeningeal disease in colorectal cancer with a regimen of bevacizumab, temozolomide, and irinotecan.

Ku GY, Krol G, Ilson DH. Ku GY, et al. J Clin Oncol. 2007 May 1;25(13):e14-6. doi: 10.1200/JCO.2006.10.3317. J Clin Oncol. 2007. PMID: 17470852 No abstract available.

4

Esophageal cancer: adjuvant therapy.

Ku GY, Ilson DH. Ku GY, et al. Cancer J. 2007 May-Jun;13(3):162-7. doi: 10.1097/PPO.0b013e318074dbe7. Cancer J. 2007. PMID: 17620765 Review.

5

Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience.

Ku GY, Minsky BD, Rusch VW, Bains M, Kelsen DP, Ilson DH. Ku GY, et al. Ann Oncol. 2008 Mar;19(3):533-7. doi: 10.1093/annonc/mdm476. Epub 2007 Oct 17. Ann Oncol. 2008. PMID: 17947223 Free article.

6

Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer.

Ku GY, Ilson DH, Schwartz LH, Capanu M, O'Reilly E, Shah MA, Kelsen DP, Schwartz GK. Ku GY, et al. Cancer Chemother Pharmacol. 2008 Oct;62(5):875-80. doi: 10.1007/s00280-008-0677-y. Epub 2008 Feb 13. Cancer Chemother Pharmacol. 2008. PMID: 18270704 Clinical Trial.

7

Preoperative therapy in esophageal cancer.

Ku GY, Ilson DH. Ku GY, et al. Clin Adv Hematol Oncol. 2008 May;6(5):371-9. Clin Adv Hematol Oncol. 2008. PMID: 18516027 Review.

8

Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction.

Ku GY, Ilson DH. Ku GY, et al. Expert Rev Anticancer Ther. 2008 Dec;8(12):1953-64. doi: 10.1586/14737140.8.12.1953. Expert Rev Anticancer Ther. 2008. PMID: 19046115 Review.

9

Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors.

Ku GY, O'Reilly EM, Saltz LB, Schrag D, Maki RG, Kelsen DP, Ilson DH. Ku GY, et al. Cancer Invest. 2009 May;27(4):402-6. doi: 10.1080/07357900802406327. Cancer Invest. 2009. PMID: 19219674 Clinical Trial.

10

Successful treatment of esophageal cancer with airway invasion with induction chemotherapy and concurrent chemoradiotherapy.

Ku GY, Goodman KA, Rusch VW, Ilson DH. Ku GY, et al. J Thorac Oncol. 2009 Mar;4(3):432-4. doi: 10.1097/JTO.0b013e3181989efa. J Thorac Oncol. 2009. PMID: 19247092 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters